The Landscape of Randomized Clinical Trial Meta-analyses on Statins for Aneurysmal Subarachnoid Hemorrhage: A Scoping Review
CONCLUSION: The limitations reported by several meta-analyses, included low patient numbers or disproportionate representation of patients from certain RCTs, differences in drug treatment, patient diagnostic criteria and outcome evaluation between RCTs, as well as poor data quality or lack of RCTs data. Knowledge of the reported limitations may aid the design of future clinical trials and/or their meta-analyses.PMID:37855296 | DOI:10.2174/0118715273270503230928100141
Source: CNS and Neurological Disorders Drug Targets - Category: Drugs & Pharmacology Authors: Panagiotis Skouras Theodosis Kalamatianos Mariam Markouli Angelos Karagiannis Lampis C Stavrinou Source Type: research
More News: Atorvastatin Calcium | Brain | Cholesterol | Clinical Trials | Disability | Drugs & Pharmacology | Lipitor | Neurology | Pravastatin | Simvastatin | Statin Therapy | Subarachnoid Hemorrhage | Zivast | Zocor